Brasada Capital Management, LP Pfizer Inc Transaction History

Brasada Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 06, 2019	SELL	$37.5 - $41.2 $23,362 - $25,667	-623 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$38.47 - $43.86 $13,041 - $14,868	-339 Reduced 35.24%	623 $27,000
Q3 2018 Nov 07, 2018	BUY	$34.47 - $41.81 $33,160 - $40,221	962 New	962 $42,000
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $38,817 - $41,383	-1,177 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $28,719 - $33,318	-900 Reduced 43.33%	1,177 $42,000
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $69,081 - $73,297	2,077	2,077 $75,000

3,226

3.61B

77.1M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $146B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Brasada Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Brasada Capital Management, LP with notifications on news.